| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Blankenship Elizabeth A | VP, Controller and CAO | 400 N. 5TH STREET, PHOENIX | /s/ Melissa Sallee, Attorney-in-Fact | 24 Feb 2026 | 0001780676 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PNW | Common Stock | Options Exercise | +490 | +5.7% | 9,111 | 20 Feb 2026 | Direct | F1 | ||
| transaction | PNW | Common Stock | Disposed to Issuer | $7,966 | -81 | -0.89% | $98.34 | 9,030 | 20 Feb 2026 | Direct | F2 |
| transaction | PNW | Common Stock | Tax liability | $12,981 | -132 | -1.5% | $98.34 | 8,898 | 20 Feb 2026 | Direct | F3 |
| transaction | PNW | Common Stock | Options Exercise | +476 | +5.3% | 9,374 | 20 Feb 2026 | Direct | F1 | ||
| transaction | PNW | Common Stock | Disposed to Issuer | $5,310 | -54 | -0.58% | $98.34 | 9,320 | 20 Feb 2026 | Direct | F2 |
| transaction | PNW | Common Stock | Tax liability | $13,374 | -136 | -1.5% | $98.34 | 9,184 | 20 Feb 2026 | Direct | F3 |
| transaction | PNW | Common Stock | Options Exercise | +589 | +6.4% | 9,773 | 20 Feb 2026 | Direct | F1 | ||
| transaction | PNW | Common Stock | Disposed to Issuer | $4,524 | -46 | -0.47% | $98.34 | 9,727 | 20 Feb 2026 | Direct | F2 |
| transaction | PNW | Common Stock | Tax liability | $15,538 | -158 | -1.6% | $98.34 | 9,569 | 20 Feb 2026 | Direct | F3 |
| transaction | PNW | Common Stock | Options Exercise | +434 | +4.5% | 10,003 | 20 Feb 2026 | Direct | F1 | ||
| transaction | PNW | Common Stock | Disposed to Issuer | $1,573 | -16 | -0.16% | $98.34 | 9,987 | 20 Feb 2026 | Direct | F2 |
| transaction | PNW | Common Stock | Tax liability | $11,112 | -113 | -1.1% | $98.34 | 9,874 | 20 Feb 2026 | Direct | F3 |
| holding | PNW | Common Stock | 54 | 20 Feb 2026 | By 401(k) |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PNW | Restricted Stock Units | Options Exercise | +490 | 0 | 20 Feb 2026 | Common Stock | 490 | Direct | F1, F4, F5 | ||||
| transaction | PNW | Restricted Stock Units | Options Exercise | +476 | +7933% | 482 | 20 Feb 2026 | Common Stock | 476 | Direct | F1, F6, F7, F8 | |||
| transaction | PNW | Restricted Stock Units | Options Exercise | +589 | +100% | 1,177 | 20 Feb 2026 | Common Stock | 589 | Direct | F1, F9, F10, F11 | |||
| transaction | PNW | Restricted Stock Units | Options Exercise | +434 | +50% | 1,305 | 20 Feb 2026 | Common Stock | 434 | Direct | F1, F12, F13, F14 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit represents a contingent right to receive the economic equivalent of one share of the Company's common stock. The Restricted Stock Units will be settled in 100% shares of common stock. |
| F2 | Represents the cash settlement of Restricted Stock Units received in connection with the settlement of dividend equivalent rights. |
| F3 | Shares retained by the Company for purpose of meeting tax withholding requirements. The recipient retained all other shares. |
| F4 | The number of derivative securities in Column 5 includes 81 vested Restricted Stock Units received in connection with the settlement of dividend equivalent rights. Dividend equivalent rights accrue with respect to these Restricted Stock Units when and as cash dividends are paid on the Company's common stock. |
| F5 | The Restricted Stock Units award was granted and was effective in February 2022, and vests in four equal, annual installments beginning on February 20, 2023. |
| F6 | The number of derivative securities in Column 5 includes 54 vested Restricted Stock Units received in connection with the settlement of dividend equivalent rights. Dividend equivalent rights accrue with respect to these Restricted Stock Units when and as cash dividends are paid on the Company's common stock. |
| F7 | The Restricted Stock Units award was granted and was effective in February 2023, and vests in four equal, annual installments beginning on February 20, 2024. |
| F8 | Includes 60 Restricted Stock Units received in connection with the settlement of dividend equivalent rights. |
| F9 | The number of derivative securities in Column 5 includes 46 vested Restricted Stock Units received in connection with the settlement of dividend equivalent rights. Dividend equivalent rights accrue with respect to these Restricted Stock Units when and as cash dividends are paid on the Company's common stock. |
| F10 | The Restricted Stock Units award was granted and was effective in February 2024, and vests in four equal, annual installments beginning on February 20, 2025. |
| F11 | Includes 91 Restricted Stock Units received in connection with the settlement of dividend equivalent rights. |
| F12 | The number of derivative securities in Column 5 includes 16 vested Restricted Stock Units received in connection with the settlement of dividend equivalent rights. Dividend equivalent rights accrue with respect to these Restricted Stock Units when and as cash dividends are paid on the Company's common stock. |
| F13 | The Restricted Stock Units award was granted and was effective in February 2025, and vests in four equal, annual installments beginning on February 20, 2026. |
| F14 | Includes 51 Restricted Stock Units received in connection with the settlement of dividend equivalent rights. |